Head-to-head · WeighScore
NuuVim vs Semaglutide Online
The verdict
Semaglutide Online takes it — 74.3/100 to 68.2/100.
Semaglutide Online grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Semaglutide Online is a LegitScript-certified telehealth platform prescribing compounded and brand-name GLP-1/GIP medications nationwide (excluding Alabama).
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | NuuVim | Semaglutide Online |
|---|---|---|
| WeighScore | 68.2/100 | 74.3/100 |
| Grade | C | C |
| Scorecard rank | #153 | #64 |
| Semaglutide | $79/mo (all doses, 3-mo plan, new patients only, compounded) | $199/mo (all doses, compounded) |
| Tirzepatide | $133/mo (all doses, 3-mo plan, new patients only, compounded) | $299/mo (all doses, compounded) |
| Coverage | Coverage not published | All 50 states |
| Brand-name access | Yes | Yes |
| Oral / sublingual | Yes | Yes |
Graded #153 · C
Strengths
- Low compounded entry pricing — semaglutide from $79/mo, tirzepatide from $133/mo, flat all-dose pricing
- Both injectable and oral compounded options for semaglutide and tirzepatide (oral access is uncommon)
- LegitScript Certified and HIPAA-compliant
- Two named compounding pharmacy partners (Hallandale Pharmacy and Pharmacy Hub), both vetted in our directory
- Operating legal entity disclosed: NuuVim LLC, Texas governing law
Where it loses points
- There is no month-to-month plan: every rate is billed as one three-month payment
- The advertised $79 and $133 are introductory rates for customers new to GLP-1s; on renewal they become $133 and $199.67
- The site's own llms.txt advertises pricing, FAQ and terms files that all 404
- No state count is published
- FDA issued this company a warning letter dated 19 March 2025; the letter is public in FDA's warning-letter database
Graded #64 · C
Strengths
- LegitScript certified — passes accreditation standards recognized by Google and Visa for online telehealth
- Compounded all-in pricing: semaglutide $199/mo and tirzepatide $299/mo includes medication, provider care, and shipping
- Brand-name options (Wegovy pill, injectable sema, Zepbound) available for eligible patients, potentially $0-$25/mo with insurance
- Nationwide (49 states + DC); no appointment required, licensed provider reviews intake within 12 hours
- 0% financing through Credee from $79/month (12-24 months) plus Affirm and Klarna with ~97% approval rate
Where it loses points
- No labs or clinical monitoring disclosed — blood work requirements not mentioned anywhere on site
- Leadership team and medical director not identified on site — no named prescribers or company founders published
- Brand-name prescriptions add a $44/month provider fee on top of medication cost, raising total price to $193-$343/mo
- No coaching, dietitian, or behavioral support at any tier — medication and async provider access only
- 30-day satisfaction guarantee covers evaluation fee only; medication costs explicitly non-refundable
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.